With breast cancer on both sides of the family, a 29-year-old Utah attorney opted to reduce her own risk drastically.

The combination of niraparib and abiraterone halves the spread of prostate cancer in men with BRCA gene mutations.

Dr. Neil Friedman from Mercy Medical Center joins Jenyne Donaldson for a conversation about genetic mutations and why it's ...

A woman is urging people with Jewish heritage to get tested for a gene which causes cancer, after her sister died of breast ...

The BRCA 14 nano-chip test, which is common in Israel, targets women of Ashkenazi and Ethiopian descent who have not been ...

Doctors warn that breast cancer is rising among women under 40, with aggressive subtypes becoming more common. Experts urge ...

A major international study led by UCL researchers has found that combining two cancer drugs could substantially slow the progression of a severe and often deadly form of prostate cancer in men with ...

Nearly 10,000 Michigan women will be diagnosed with breast cancer this year. Over the summer, I learned that number would ...

While genetics play a key role in breast cancer risk, experts emphasize that lifestyle, environmental factors, and hormonal ...

Marie Parker and her daughter Madalyn are previvors. The term, coined in 2000 by members of the nonprofit Facing Our Risk of ...

As Breast Cancer Awareness Month continues to gain attention across Europe, new initiatives are underway to strengthen early ...